🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Healthy Control Subjects

Satiety, Microbiome, Appetite Regulation, and Tracking Energy Across Targeted Snacks: Chronic Study NCT07782593NA1 site📍 London Zoe Global Limited · Tests: High-fibre plant-based snack bar, Control snack bars Effects of Respiratory Muscle Training on Tongue Muscle Function NCT06627283NA3 sites📍 Leuven📍 Louvain-la-Neuve📍 Lausanne Université Catholique de Louvain · Tests: IMT, EMT, Sham Study of AT-587 in Healthy Subjects NCT07728487Phase 11 site📍 Edegem Atea Pharmaceuticals, Inc. · Tests: AT-587, Placebo A Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SYH2070 Injection NCT07241923Phase 11 site📍 Shijiazhuang CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. · Tests: SYH2070 injection, Placebo Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of BSY001 After Single/Multiple Doses. NCT07377175Phase 11 site📍 Hangzhou China National Biotec Group Company Limited · Tests: BSY001 for Injection (37.5mg), BSY001 for Injection (75 mg), BSY001 for Injection (150 mg), BSY001 for Injection (200 m… A Phase 1 Study of PVT401 in Healthy Subjects NCT07423000Phase 11 site📍 Melbourne Parvus Therapeutics, Inc. · Tests: PVT401, Normal Saline (0.9% NaCl) Safety, Tolerability, and Pharmacokinetics of Single Doses of HC022 in Healthy Subjects. NCT06657703Phase 13 sites📍 Beijing📍 Beijing📍 Beijing HC Biopharma Inc. · Tests: HC022, Placebo Comparison of DW-1021 and Separate Doses of Pelubi CR and Zytram CR Under Fasting Conditions NCT07032558Phase 12 sites📍 Haiphong📍 Haiphong Haiphong University of Medicine and Pharmacy · Tests: DW-1021, Pelubi CR + Zytram CR A Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ALE1 in Healthy Adults and Adults With Hypophosphatasia in Order to Identify Suitable Doses of ALE1 NCT07179640Phase 1, Phase 23 sites📍 Würzburg📍 Grafton📍 Leeds Alesta Therapeutics · Tests: ALE1, Placebo A Study to Assess the Safety, Tolerability and How Single Ascending Doses of ABBV-859 Moves Through the Body of Healthy Adult Participants NCT07736638Phase 12 sites📍 Anaheim📍 Grayslake AbbVie · Tests: ABBV-859, Placebo for ABBV-859, ABBV-859, Placebo for ABBV-859 Reactive Balance Training in Augmented Reality for Older Adults NCT07860619NA1 site📍 Hong Kong The Hong Kong Polytechnic University · Tests: Reactive balance training with augmented reality group, Treadmill walking First-in-Human Single and Multiple Dose of HL-400 NCT06997484Phase 11 site📍 Baltimore Highlightll Pharmaceutical (USA) LLC · Tests: HL-400, Placebo A Study to Assess the Adverse Events and How Oral Emraclidine Moves Through the Body of Healthy Elderly Adult Participants NCT07219030Phase 15 sites📍 Cypress📍 Maitland📍 Miami AbbVie · Tests: Emraclidine, Placebo A Safety and Tolerability Study of BPR-30221616 Injection in Healthy Subjects NCT06760455Phase 11 site📍 Beijing Chengdu Brilliant Pharmaceutical Co., Ltd. · Tests: BPR-30221616 Injection, Sodium Chloride Injection Screening of Healthy Volunteers for Investigational Antimalarial Drugs, Malaria Vaccines, and Controlled Human Malaria Challenge NCT02639299n/a1 site📍 Bethesda National Institute of Allergy and Infectious Diseases (NIAI… A Study on the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of RS-C1001 Tablets in Chinese Healthy Subjects NCT06669429Phase 11 site📍 Beijing Peking University First Hospital · Tests: RS-C1001, RS-C1001, RS-C1001, placebo, placebo A Phase 1/2a Study of Oral PRO-1562 in Healthy Subjects and Patients With Relapsing Multiple Sclerosis NCT07826689Phase 1, Phase 21 site📍 Adelaide Progentos Therapeutics · Tests: PRO-1562 Oral Capsules, Placebo Oral Capsule A Study of FB1003 in Healthy and Osteoarthritis Pain Subjects NCT06343714Phase 12 sites📍 Brisbane📍 Bayswater 4B Technologies Limited · Tests: FB1003, Placebo The Effects of Chicory Root-derived Prebiotic on Mood and Stress Responsiveness in Healthy Adults With Mild to Moderate Levels of Stress and Anxiety NCT07058324NA1 site📍 Trier Beneo-Institute · Tests: Prebiotic fiber, Placebo control A Phase 1 Study to Evaluate the Safety and Pharmacokinetics of ABBV-243 in Healthy Adults. NCT07306754Phase 11 site📍 Grayslake AbbVie · Tests: ABBV-243, Placebo, ABBV-243, Placebo Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ICP-538 in Healthy Subjects NCT07535099Phase 11 site📍 Beijing Beijing InnoCare Pharma Tech Co., Ltd. · Tests: ICP-538 Tablets, ICP-538 placebo Tablets A Study of CYT-1010 in Healthy Volunteers and Participants With Acute Pain After Third Molar Extraction NCT07905105Phase 1, Phase 21 site📍 Salt Lake City Cytogel Pharma, LLC · Tests: CYT-1010, Placebo A First in Human Study to Evaluate Safety, Tolerability, Pharmacology of HS-10390 in Healthy Subjects NCT05942625Phase 11 site📍 Nanjing Hansoh BioMedical R&D Company · Tests: HS-10390 tablet, Placebo tablet Food Effect on PK of DW-1021 (Pelubiprofen 45 mg / Tramadol 45.9 mg) in Healthy Adults NCT07060209Phase 12 sites📍 Haiphong📍 Haiphong Haiphong University of Medicine and Pharmacy · Tests: DW-1021 Effects of Hip Bump Manipulation Versus Sham Treatment in Healthy Adults NCT07025434NA1 site📍 Orangeburg Dominican University New York · Tests: Hip Bump Manipulation, Sham (No Treatment) A Study of ORX142 in Healthy Adult Subjects, Including Subjects 18 to 80 Years of Age NCT07082829Phase 13 sites📍 Lincoln📍 Eatontown📍 New York Centessa Pharmaceuticals (UK) Limited · Tests: ORX142 Tablets, Placebo Tablets A Study to Evaluate the Safety, Tolerability, PK/PD of HEC-007 Injection in Healthy and Overweight/Obese Subjects NCT07102251Phase 11 site📍 Hefei Sunshine Lake Pharma Co., Ltd. · Tests: HEC-007 injection, Placebo, HEC-007 injection, Placebo A Phase Ia Clinical Trial of HW241045 NCT07448194Phase 11 site📍 Beijing Hubei Bio-Pharmaceutical Industrial Technological Institute… · Tests: HW241045, Placebo Evaluate the Efficacy, Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females NCT04422366Phase 31 site📍 Liuzhou Shanghai Bovax Biotechnology Co., Ltd. · Tests: 9-valent Human Papillomavirus (Types 6, 11, 16, 18,31,33,45,52 and 58) Recombinant Vaccine (Hansenula Polymorpha), GARD… First-in-human Study of HSK56630 in Healthy Subjects NCT07580794Phase 11 site📍 Bayswater Haisco Pharmaceutical Group Co., Ltd. · Tests: HSK56630, Placebo
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy